<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoV-2 is more likely to affect middle-aged and elderly people, especially those with comorbidities, as a result of the weaker immune functions of these patients (
 <xref rid="B18" ref-type="bibr">Chen N. et al., 2020</xref>). About 1/4âˆ¼1/2 patients infected by SARS-CoV-2 had chronic comorbidities, and the prognosis was strongly associated with the presence and number of comorbidities (
 <xref rid="B18" ref-type="bibr">Chen N. et al., 2020</xref>; 
 <xref rid="B38" ref-type="bibr">Guan et al., 2020a</xref>). Malignancy and chronic obstructive pulmonary disease (COPD) appeared to be the main risk factors leading to poorer clinical outcomes, followed by diabetes and hypertension, according to a retrospective study of 1099 COVID-19 cases (
 <xref rid="B38" ref-type="bibr">Guan et al., 2020a</xref>). Therefore, immune disorders and long-term chronic inflammatory stimulation are likely to be key drivers to poor prognosis, however more mechanism studies are needed to confirm this.
</p>
